Atlas Trials

Double-blind, Randomized, Controlled Study of Safety, Immunogenicity and Efficacy of a Candidate Malaria Vaccine

Clinical trial NCT00223990 · COMPLETED

Trial details

NCT number
NCT00223990
Sponsor
U.S. Army Medical Research and Development Command
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Malaria, Falciparum
Start date
2005-04-08
Primary completion
2006-04-26
Enrollment
400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.